findmyKOL
Clinical trialNCT04721704UnknownInterventional

Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children

SponsorShaheed Zulfiqar Ali Bhutto Medical UniversityEnrollment36H Pylori Gastritis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

All children from 1day to 18years of age, diagnosed with peptic ulcer disease due to H pylori at Pakistan Institute of Medical Sciences, Islamabad, from July 2020 to December 2021 will be included in the study. After informed written consent from parents/ guardians patients' bio data along with history and examination will be recorded on a proforma. They will be allocated into two groups, group A and group B randomly based on treatment regimen offered. Group A: Amoxicillin AMO + Clarithromycin CLA + Proton pump inhibitor PPI) Group B: Amoxicillin AMO+ Metronidazole MET+ Proton pump inhibitor PPI The history will include presenting symptoms along duration, remission of symptoms after therapy and clinical outcome will also be recorded.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pakistan
  • Pakistan Institute of Medical Sciences,szabmu

    Islamabad, Capital Territory, Pakistan

    Jai Krishin, FCPS
    Recruiting
  • Pakistan Institute of Medical Sciences, Islamabad

    Islamabad, Islamabad, Pakistan

    Jai Krishin, FCPS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AMOXICILLIN/CLARITHROMYCIN/OMEPRAZOLEMetronidazole +Amoxicillin + Omeprazole
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Sept 2020
Primary completion
14 Sept 2022
Completion
14 Sept 2022
Last update posted
26 Jan 2021
Registered enrollment
36
Registry id
NCT04721704
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.